{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:09:34Z","timestamp":1750306174530,"version":"3.41.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.7759\/cureus.86244","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:42:10Z","timestamp":1750218130000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Myasthenia Gravis With Underlying Aldolase A Deficiency: Diagnostic and Therapeutic Challenges"],"prefix":"10.7759","author":[{"given":"Niyas Khalid","family":"Ottu Para","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyashri","family":"Ramanathan Nagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daya","family":"Mani Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diya","family":"Viju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-823912-4.00026-8","article-title":"Myasthenia gravis-pathophysiology, diagnosis, and treatment","volume":"200","author":"Tannemaat MR","year":"2024","unstructured":"Tannemaat MR, Huijbers MG, Verschuuren JJ. Myasthenia gravis-pathophysiology, diagnosis, and treatment. Handb Clin Neurol. 2024, 200:283-305. 10.1016\/B978-0-12-823912-4.00026-8","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:2235. 10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2018.1529669","article-title":"A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences","volume":"129","author":"Asmail A","year":"2019","unstructured":"Asmail A, Kesler A, Kolb H, Drory VE, Karni A. A tri-modal distribution of age-of-onset in female patients with myasthenia gravis is associated with the gender-related clinical differences. Int J Neurosci. 2019, 129:313-319. 10.1080\/00207454.2018.1529669","journal-title":"Int J Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2021.100730","article-title":"Aldolase A deficiency: report of new cases and literature review","volume":"27","author":"Papadopoulos C","year":"2021","unstructured":"Papadopoulos C, Svingou M, Kekou K, Vergnaud S, Xirou S, Niotakis G, Papadimas GK. Aldolase A deficiency: report of new cases and literature review. Mol Genet Metab Rep. 2021, 27:100730. 10.1016\/j.ymgmr.2021.100730","journal-title":"Mol Genet Metab Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01228-3","article-title":"A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report","volume":"48","author":"Santoro L","year":"2022","unstructured":"Santoro L, Pjetraj D, Velmishi V, Campana C, Catassi C, Dionisi-Vici C, Maiorana A. A new phenotype of aldolase a deficiency in a 14 year-old boy with epilepsy and rhabdomyolysis - case report. Ital J Pediatr. 2022, 48:39. 10.1186\/s13052-022-01228-3","journal-title":"Ital J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.569818","article-title":"Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients","volume":"11","author":"Li Y","year":"2020","unstructured":"Li Y, Zhang Y, Wang Y, et al.. Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients. Front Immunol. 2020, 11:569818. 10.3389\/fimmu.2020.569818","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105464","article-title":"Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review","volume":"172","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhang Y, et al.. Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A review. Neurochem Int. 2024, 172:105464. 10.1016\/j.neuint.2024.105464","journal-title":"Neurochem Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami P","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, et al.. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021, 96:114-122. 10.1212\/WNL.0000000000011124","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4902291","article-title":"Anti-Aldoa antibody: a novel diagnostic-associated autoantibody in myasthenia gravis","author":"Yu X","year":"2024","unstructured":"Yu X, Hu G, Zhu X, et al.. Anti-Aldoa antibody: a novel diagnostic-associated autoantibody in myasthenia gravis. SSRN. 2024, 10.2139\/ssrn.4902291","journal-title":"SSRN"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-AChR antibody-positive refractory generalized MG (REGAIN)","volume":"16","author":"Howard JF Jr","year":"2017","unstructured":"Howard JF Jr, Utsugisawa K, Benatar M, et al.. Safety and efficacy of eculizumab in anti-AChR antibody-positive refractory generalized MG (REGAIN). Lancet Neurol. 2017, 16:976-986. 10.1016\/S1474-4422(17)30369-1","journal-title":"Lancet Neurol"},{"key":"ref11","article-title":"Fructose-1-phosphate aldolase deficiency","author":"Ahmad U","year":"2025","unstructured":"Ahmad U, Sharma J. Fructose-1-phosphate aldolase deficiency. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00538","article-title":"Novel treatments in myasthenia gravis","volume":"11","author":"Menon D","year":"2020","unstructured":"Menon D, Barnett C, Bril V. Novel treatments in myasthenia gravis. Front Neurol. 2020, 11:538. 10.3389\/fneur.2020.00538","journal-title":"Front Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375237-a-rare-case-of-myasthenia-gravis-with-underlying-aldolase-a-deficiency-diagnostic-and-therapeutic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:42:11Z","timestamp":1750218131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375237-a-rare-case-of-myasthenia-gravis-with-underlying-aldolase-a-deficiency-diagnostic-and-therapeutic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.86244","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}